Patients’ View Of Drug Value Is Focus Of Avalere/FasterCures Framework

Cost considerations will be limited to those borne by patients under value framework that is expected to be used initially to support patient-clinician decisions on appropriate treatment.

Bottles

More from Health Technology Assessment

More from Market Access